77 related articles for article (PubMed ID: 29698191)
1. From Regulatory Approval to Subsidized Patient Access in the Asia-Pacific Region: A Comparison of Systems Across Australia, China, Japan, Korea, New Zealand, Taiwan, and Thailand.
Cook G; Kim H
Value Health Reg Issues; 2015 May; 6():40-45. PubMed ID: 29698191
[TBL] [Abstract][Full Text] [Related]
2. From Regulatory Approval to Subsidised Patient Access in the Asia-Pacific Region: A Comparison of Systems Across Australia, China, Japan, Korea, New Zealand, Taiwan And Thailand.
Kim H; Jung H; Chou P; Kunihara T; Tosanguan J; Tang Z; Brydon S; Cook G
Value Health; 2014 Nov; 17(7):A794. PubMed ID: 27202972
[No Abstract] [Full Text] [Related]
3. Evidence-based decision-making in Asia-Pacific with rapidly changing health-care systems: Thailand, South Korea, and Taiwan.
Jirawattanapisal T; Kingkaew P; Lee TJ; Yang MC
Value Health; 2009; 12 Suppl 3():S4-11. PubMed ID: 20586980
[TBL] [Abstract][Full Text] [Related]
4. A 3-dimensional view of access to licensed and subsidized medicines under single-payer systems in the US, the UK, Australia and New Zealand.
Ragupathy R; Aaltonen K; Tordoff J; Norris P; Reith D
Pharmacoeconomics; 2012 Nov; 30(11):1051-65. PubMed ID: 22963187
[TBL] [Abstract][Full Text] [Related]
5. Pharmaceutical Policy Reforms to Regulate Drug Prices in the Asia Pacific Region: The Case of Australia, China, India, Malaysia, New Zealand, and South Korea.
Hasan SS; Kow CS; Dawoud D; Mohamed O; Baines D; Babar ZU
Value Health Reg Issues; 2019 May; 18():18-23. PubMed ID: 30414506
[TBL] [Abstract][Full Text] [Related]
6. The impact of pharmaceutical cost containment policies on the range of medicines available and subsidized in Finland and New Zealand.
Aaltonen K; Ragupathy R; Tordoff J; Reith D; Norris P
Value Health; 2010; 13(1):148-56. PubMed ID: 19744294
[TBL] [Abstract][Full Text] [Related]
7. Comparisons of guardianship laws and surrogate decision-making practices in China, Japan, Thailand and Australia: a review by the Asia Consortium, International Psychogeriatric Association (IPA) capacity taskforce.
Tsoh J; Peisah C; Narumoto J; Wongpakaran N; Wongpakaran T; O'Neill N; Jiang T; Ogano S; Mimura M; Kato Y; Chiu H
Int Psychogeriatr; 2015 Jun; 27(6):1029-37. PubMed ID: 25573420
[TBL] [Abstract][Full Text] [Related]
8. Survey on medical records and EHR in Asia-Pacific region: languages, purposes, IDs and regulations.
Kimura M; Croll P; Li B; Wong CP; Gogia S; Faud A; Kwak YS; Chu S; Marcelo A; Chow YH; Paoin W; Li YC
Methods Inf Med; 2011; 50(4):386-91. PubMed ID: 21792467
[TBL] [Abstract][Full Text] [Related]
9. A review of accessibility of administrative healthcare databases in the Asia-Pacific region.
Milea D; Azmi S; Reginald P; Verpillat P; Francois C
J Mark Access Health Policy; 2015; 3():. PubMed ID: 27123180
[TBL] [Abstract][Full Text] [Related]
10. Reimbursement Coverage and Pricing Systems for Single-Use Devices in Asia-Pacific: Japan, Taiwan, Korea, and Australia Compared.
Lee SS; Symonds D; Kamogawa S; Sato M; Chiang E; Salole E
Value Health Reg Issues; 2015 May; 6():126-129. PubMed ID: 29698183
[TBL] [Abstract][Full Text] [Related]
11. Health technology assessment in the Asia Pacific region.
Sivalal S
Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():196-201. PubMed ID: 19534841
[TBL] [Abstract][Full Text] [Related]
12. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data.
Johnson DW; Dent H; Yao Q; Tranaeus A; Huang CC; Han DS; Jha V; Wang T; Kawaguchi Y; Qian J
Nephrol Dial Transplant; 2009 May; 24(5):1598-603. PubMed ID: 19096083
[TBL] [Abstract][Full Text] [Related]
13. Patient access schemes in Asia-pacific markets: current experience and future potential.
Lu CY; Lupton C; Rakowsky S; Babar ZU; Ross-Degnan D; Wagner AK
J Pharm Policy Pract; 2015; 8(1):6. PubMed ID: 25815200
[TBL] [Abstract][Full Text] [Related]
14. Government regulation of pricing and reimbursement of prescription medicines: results of a recent multi-country review.
Kingham R; Wheeler J
Food Drug Law J; 2009; 64(1):101-14. PubMed ID: 19998574
[TBL] [Abstract][Full Text] [Related]
15. Use of targeted therapies for advanced renal cell carcinoma in the Asia-Pacific region: opinion statement from China, Japan, Taiwan, Korea, and Australia.
Ye D; Eto M; Chung JS; Kimura G; Chang WC; Chang YH; Pang ST; Lee JL; Niu Y; Gurney H; Uemura H
Clin Genitourin Cancer; 2014 Aug; 12(4):225-33. PubMed ID: 24630778
[TBL] [Abstract][Full Text] [Related]
16. Evidence-based decision on medical technologies in Asia Pacific: experiences from India, Malaysia, Philippines, and Pakistan.
Thatte U; Hussain S; de Rosas-Valera M; Malik MA
Value Health; 2009; 12 Suppl 3():S18-25. PubMed ID: 20586975
[TBL] [Abstract][Full Text] [Related]
17. Needs for hepatocellular carcinoma control policy in the Asia-Pacific region.
Bridges JF; Joy SM; Gallego G; Kudo M; Ye SL; Han KH; Cheng AL; Blauvelt BM
Asian Pac J Cancer Prev; 2011; 12(10):2585-91. PubMed ID: 22320959
[TBL] [Abstract][Full Text] [Related]
18. Current diagnosis and management of mucopolysaccharidosis VI in the Asia-Pacific region.
Hwu WL; Okuyama T; But WM; Estrada S; Gu X; Hui J; Kosuga M; Lin SP; Ngu LH; Shi H; Tanaka A; Thong MK; Wattanasirichaigoon D; Wasant P; McGill J
Mol Genet Metab; 2012 Sep; 107(1-2):136-44. PubMed ID: 22864057
[TBL] [Abstract][Full Text] [Related]
19. Psychoneuroimmunology goes East: Development of the PNIRS
Kelley KW; Peng YP; Liu Q; Chang HC; Spencer SJ; Hutchinson MR; Shimada A
Brain Behav Immun; 2020 Aug; 88():75-87. PubMed ID: 32304882
[TBL] [Abstract][Full Text] [Related]
20. Insights, attitudes and perceptions about asthma and its treatment: findings from a multinational survey of patients from 8 Asia-Pacific countries and Hong Kong.
Thompson PJ; Salvi S; Lin J; Cho YJ; Eng P; Abdul Manap R; Boonsawat W; Hsu JY; Faruqi RA; Moreno-Cantu JJ; Fish JE; Ho JC
Respirology; 2013 Aug; 18(6):957-67. PubMed ID: 23730953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
